The babel of drugs: On the consequences of evidential pluralism in pharmaceutical regulation and regulatory data journeys

1. Tempini, N.
2. Teira, D.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1007/978-3-030-37177-7_11 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus